Stay updated with breaking news from Nasdaq Krtx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Karuna Therapeutics (NASDAQ:KRTX – Free Report) had its price objective lowered by Mizuho from $274.00 to $258.00 in a research report report published on Friday, Marketbeat Ratings reports. The brokerage currently has a buy rating on the stock. Other research analysts have also issued reports about the stock. JPMorgan Chase & Co. dropped their price […]
HC Wainwright reiterated their buy rating on shares of Karuna Therapeutics (NASDAQ:KRTX – Free Report) in a report published on Friday morning, Benzinga reports. HC Wainwright currently has a $300.00 price target on the stock. KRTX has been the topic of several other research reports. JPMorgan Chase & Co. lowered their price objective on shares […]
EFG Asset Management North America Corp. raised its position in Karuna Therapeutics, Inc. (NASDAQ:KRTX – Free Report) by 16.8% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 6,858 shares of the company’s stock after purchasing an additional 987 shares during […]
Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Rating) – Investment analysts at Zacks Research lowered their FY2025 EPS estimates for Karuna Therapeutics in a research note issued on Thursday, June 15th. Zacks Research analyst S. Ganoria now forecasts that the company will earn ($5.07) per share for the year, down from their previous forecast of ($4.81). […]
Karuna Therapeutics (NASDAQ:KRTX – Get Rating) had its target price trimmed by JPMorgan Chase & Co. from $260.00 to $250.00 in a report issued on Monday morning, The Fly reports. A number of other brokerages have also recently issued reports on KRTX. Mizuho increased their price objective on Karuna Therapeutics from $270.00 to $274.00 in […]